Agentic automation in life sciences is transforming how organizations operate by combining AI agents, robots, and human oversight to execute complex, goal-driven workflows. Unlike traditional rule-based bots, agents use probabilistic reasoning to manage dynamic, high-value processes across functions like finance, patient eligibility, clinical trials, cell and gene therapy, and drug discovery. UiPath’s platform enables seamless integration across enterprise systems while ensuring regulatory compliance and auditability. By starting with high-effort, low-risk use cases and leveraging existing automation, life sciences companies can accelerate innovation, enhance accuracy, and reduce time to market.

Join for free to read